Results of surgery for congenital esotropia.

INTRODUCTION: Congenital esotropia is a convergent deviation of the eyes when fixating on an object. It appears during the first six months of life and affects muscle structure and physiology, as well as the relation of the eyes with the environment, retinal relations and neural integration phenomena. Amblyopia develops in 30-50% of those affected. Timely surgery is effective in most cases. OBJECTIVE: Describe surgical results in congenital esotropia cases treated in the Pediatric Ophthalmology and Strabismus Service of the Ramon Pando Ferrer Ophthalmology Institute in Havana between January 2008 and May 2009. METHODS: A descriptive, retrospective study was carried out through review of 127 cases (aged 1-18 years, 55 male and 72 female) operated on for congenital esotropia between January 2008 and May [corrected] 2009. Variables used were: age at surgery, degree of preoperative amblyopia, type of fixation, refractive error, associated conditions, type of surgery performed and pre- and postoperative deviation angles. RESULTS: The largest number of congenital esotropia cases were found in children <2 years old (38.6%). Before surgery, 37% of cases studied showed mild amblyopia; 22.8% moderate and 12.6% severe; 27.6% did not cooperate with visual acuity testing. With respect to fixation: 91.3% showed central fixation and 8.7% eccentric. Refractive errors found were: mild hyperopia (65.4%), moderate hyperopia (29.1%), and myopia (5.5%). Associated conditions were: overaction of the inferior oblique muscles (48%), latent nystagmus (16.5%), and dissociated vertical deviation (8.7%); no alterations were found in 26.8% of cases. The most frequently used surgical treatment was bilateral medial rectus muscle recession (92.1%). The most common preoperative deviation angle range was 31­40 prism diopters (PD) in 51.9% of patients; the postoperative deviation angle most commonly found after 12 months was <10 PD in 64.6% (orthotropia). CONCLUSIONS: Surgery, most commonly with medial rectus muscle resection, was effective in correcting congenital esotropia.

Uso de la triamcinolona subtenoniana en pacientes con rubeosis del iris / Use of intravitreal triamcinolone in patients with iris rubeosis

Describir el comportamiento de la rubeosis del iris luego de la aplicación de triamcinolona subtenoniana. Se realizó un estudio descriptivo de corte longitudinal con 25 pacientes para un total de 32 ojos con diferentes afecciones oculares. Se efectuaron pruebas estadísticas con las variables del estudio y en algunas se utilizó la prueba de los signos de comparación para datos pareados y en otras se aplicó chi cuadrado. Se caracterizaron las variables: edad, sexo, causa de rubeosis del iris y sus estadios, síntomas y tratamiento con láser de panfotocoagulación retiniana. La retinopatía diabética proliferativa fue la afección más frecuente en el 76 por ciento de los pacientes, seguida de la oclusión de la vena central retiniana. Del total de pacientes tratados, el 37,5 por ciento evolucionó satisfactoriamente el estado de la rubeosis del iris. Fue mayor el número de pacientes que mejoraron el grado de la rubeosis con tratamiento combinado de láser y triamcinolona subtenoniana, aunque estadísticamente no fue significativo. El estado de la rubeosis mejoró en más de la mitad de los pacientes con tiempo de evolución menor de 6 meses. En aquellos con un tiempo mayor de 6 meses y neovascularización del iris grado III, se pudo estabilizar el glaucoma neovascular. Se plantea que la triamcinolona subtenoniana constituye una alternativa para el manejo de este tipo de pacientes(AU)

To describe the behaviour of iris rubeosis after using intravitreal triamcinolone. A longitudinal descriptive study was performed on 25 patients for a total number of 32 eyes with several ocular diseases. Statistical tests were made with the study variables; sign comparison for paired data and Chi square tests were applied. The variables were age, sex, cause of iris rubeosis and its staging, symptoms and treatment with retinal photocoagulation laser. Proliferative diabetic retinopathy was the most common disease in 76 percent of patients, followed by central retinal vein occlusion. Of the total number of treated patients, 37,5 percent had satisfactory recovery in terms of the iris rubeosis condition. The number of patients that improved rubeosis condition after a combined therapy of laser and intravitreal triamcinolone was higher but not statistically significant. Rubeosis condition improved in over 50 percent of patients whose rubeosis had developed in less than six months. However, in those patients with the disease affecting them for more than 6 months and third grade iris neovascularization, neovascular glaucoma could be stabilized. Intravitreal triamcinolone is an alternative for the management of this type of patients(AU)